TABLE 3.
Clinical outcomes of hospitalized SARS‐CoV‐2‐infected patients with a BMI ≥25 by EOSS stage
| Characteristic | EOSS 0/1, N = 93 | EOSS 1/2, N = 286 | EOSS 3/4, N = 147 | p value |
|---|---|---|---|---|
| Clinical outcomes | ||||
| Length of hospitalization, days | 6.00 (6.00)a | 8.00 (8.00)b | 7.00 (10.00)a,b | <.001 |
| AKI | 0 | 27 | 49 | <.001 |
| 0% | 9% | 33% | ||
| ICU admission | 3 | 77 | 50 | <.001 |
| 3% | 27% | 34% | ||
| Mechanical ventilation | 0 | 53 | 38 | <.001 |
| 0% | 19% | 26% | ||
| Length of mechanical ventilation, days | 10.00 (11.00) | 13.50 (10.00) | .149 | |
| Mortality | 0 | 8 | 11 | <.001 |
| 0% | 3% | 7% |
Note: Groups with different superscripted letters are significantly different from each other by Dunn–Bonferonni's pairwise test. Continuous dependent variables reported as median (IQR).
Abbreviations: AKI, acute kidney injury; BMI, body mass index; EOSS, Edmonton Obesity Staging System; ICU, intensive care unit; IQR, interquartile range.